Check medicine papers: citations, claims and retractions

Development and validation of the international knee documentation committee subjective knee form

Irrgang, J. J., Anderson, A. F., Boland, A. L., Harner, C. D., Kurosaka, M., Neyret, P., Richmond, J. C., & Shelborne, K. D. (2001) · The American Journal of Sports Medicine

Knee injuries and reconstruction techniquesMusculoskeletal pain and rehabilitation

Cited by 2,204

Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder

ADHD Working Group of the Psychiatric Genomics Consortium (PGC), Demontis, D., Early Lifecourse & Genetic Epidemiology (EAGLE) Consortium, 23andMe Research Team, Walters, R. K., Martin, J., Mattheisen, M., Als, T. D., Agerbo, E., Baldursson, G., et al. (2019) · Nature Genetics

Attention Deficit Hyperactivity DisorderGenetic Associations and Epidemiology

Cited by 2,203

Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study

Armstrong, M. J., Gaunt, P., Aithal, G. P., Barton, D., Hull, D., Parker, R., Hazlehurst, J. M., Guo, K., Abouda, G., Aldersley, M. A., et al. (2016) · The Lancet

Liver Disease Diagnosis and TreatmentDiabetes Treatment and Management

Cited by 2,203

Too Much Sitting: The Population Health Science of Sedentary Behavior

Owen, N., Healy, G. N., Matthews, C. E., & Dunstan, D. W. (2010) · Exercise and Sport Sciences Reviews

Physical Activity and HealthErgonomics and Musculoskeletal Disorders

Cited by 2,202

Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness

Horne, R., & Weinman, J. (1999) · Journal of Psychosomatic Research

Medication Adherence and CompliancePharmacy and Medical Practices

Cited by 2,201

The economic burden of physical inactivity: a global analysis of major non-communicable diseases

Ding, D., Lawson, K. D., Kolbe-Alexander, T. L., Finkelstein, E. A., Katzmarzyk, P. T., van Mechelen, W., & Pratt, M. (2016) · The Lancet

Physical Activity and HealthHealth Systems, Economic Evaluations, Quality of Life

Cited by 2,201

Obesity and Diabetes in the Developing World — A Growing Challenge

Hossain, P., Kawar, B., & El Nahas, M. (2007) · New England Journal of Medicine

Obesity, Physical Activity, DietDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 2,200

A modification of the elixhauser comorbidity measures into a point system for hospital death using administrative data

van Walraven, C., Austin, P. C., Jennings, A., Quan, H., & Forster, A. J. (2009) · Medical Care

Chronic Disease Management StrategiesMedical Coding and Health Information

Cited by 2,200

Adolescence and the social determinants of health

Viner, R. M., Ozer, E. M., Denny, S., Marmot, M., Resnick, M., Fatusi, A., & Currie, C. (2012) · The Lancet

Adolescent Health and BehaviorsHealth disparities and outcomes

Cited by 2,199

TP53 mutations in human cancers: origins, consequences, and clinical use.

Olivier, M., Hollstein, M., & Hainaut, P. (2010) · Cold Spring Harbor Perspectives in Biology

Cancer-related Molecular PathwaysCancer Genomics and Diagnostics

Cited by 2,199

Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial

Balar, A. V., Galsky, M. D., Rosenberg, J. E., Powles, T., Petrylak, D. P., Bellmunt, J., Loriot, Y., Necchi, A., Hoffman-Censits, J., Perez-Gracia, J. L., et al. (2017) · The Lancet

Bladder and Urothelial Cancer TreatmentsCancer Immunotherapy and Biomarkers

Cited by 2,199

Osteosarcoma incidence and survival rates from 1973 to 2004: Data from the Surveillance, Epidemiology, and End Results Program

Mirabello, L., Troisi, R. J., & Savage, S. A. (2009) · Cancer

Sarcoma Diagnosis and TreatmentBone Tumor Diagnosis and Treatments

Cited by 2,199

U. S. Householder survey of functional gastrointestinal disorders: Prevalence, sociodemography, and health impact

Drossman, D. A., Li, Z., Andruzzi, E., Temple, R. D., Talley, N. J., Grant Thompson, W., Whitehead, W. E., Janssens, J., Funch-Jensen, P., Corazziari, E., et al. (1993) · Digestive Diseases and Sciences

Gastrointestinal motility and disordersPsychosomatic Disorders and Their Treatments

Cited by 2,198

A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules

Aspelund, A., Antila, S., Proulx, S. T., Karlsen, T. V., Karaman, S., Detmar, M., Wiig, H., & Alitalo, K. (2015) · Journal of Experimental Medicine

Cerebrospinal fluid and hydrocephalusLymphatic System and Diseases

Cited by 2,198

Elexacaftor–Tezacaftor–Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele

Middleton, P. G., Mall, M. A., Dřevínek, P., Lands, L. C., McKone, E. F., Polineni, D., Ramsey, B. W., Taylor-Cousar, J. L., Tullis, E., Vermeulen, F., et al. (2019) · New England Journal of Medicine

Cystic Fibrosis Research AdvancesInhalation and Respiratory Drug Delivery

Cited by 2,198

US trends in prevalence, awareness, treatment, and control of hypertension, 1988–2008

Egan, B. M. (2010) · JAMA

Blood Pressure and Hypertension StudiesSodium Intake and Health

Cited by 2,197

Prevalence of lysosomal storage disorders

Meikle, P. J. (1999) · JAMA

Lysosomal Storage Disorders ResearchGlycogen Storage Diseases and Myoclonus

Cited by 2,197

Global burden of primary liver cancer in 2020 and predictions to 2040

Rumgay, H., Arnold, M., Ferlay, J., Lesi, O., Cabasag, C. J., Vignat, J., Laversanne, M., McGlynn, K. A., & Soerjomataram, I. (2022) · Journal of Hepatology

Hepatocellular Carcinoma Treatment and PrognosisGlobal Cancer Incidence and Screening

Cited by 2,197

2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain

Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., & Waku, K. (1995) · Biochemical and Biophysical Research Communications

Cannabis and Cannabinoid ResearchNeuroscience and Neuropharmacology Research

Cited by 2,196

Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma

Provenzano, P. P., Cuevas, C., Chang, A. E., Goel, V. K., Von Hoff, D. D., & Hingorani, S. R. (2012) · Cancer Cell

Pancreatic and Hepatic Oncology ResearchCellular Mechanics and Interactions

Cited by 2,195

A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation

Ramsey, B. W., Davies, J., McElvaney, N. G., Tullis, E., Bell, S. C., Dřevínek, P., Griese, M., McKone, E. F., Wainwright, C. E., Konstan, M. W., et al. (2011) · New England Journal of Medicine

Cystic Fibrosis Research AdvancesInhalation and Respiratory Drug Delivery

Cited by 2,195

Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes

Umpierrez, G. E., Isaacs, S. D., Bazargan, N., You, X., Thaler, L. M., & Kitabchi, A. E. (2002) · The Journal of Clinical Endocrinology & Metabolism

Hyperglycemia and glycemic control in critically ill and hospitalized patientsDiabetes Management and Research

Cited by 2,195

Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma

Moffitt, R. A., Marayati, R., Flate, E. L., Volmar, K. E., Loeza, S. G. H., Hoadley, K. A., Rashid, N. U., Williams, L. A., Eaton, S. C., Chung, A. H., et al. (2015) · Nature Genetics

Pancreatic and Hepatic Oncology ResearchGene expression and cancer classification

Cited by 2,194

Idiopathic pulmonary fibrosis

King, T. E., Pardo, A., & Selman, M. (2011) · The Lancet

Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisOccupational and environmental lung diseases

Cited by 2,194